Multiple randomized controlled trials have shown their use lowers the risk of arterial thromboembolic events, including heart attack and stroke, and observational studies have reported correlations between statin use and lower DVT/pulmonary embolism risk
Genetic variants in antioxidant pathways: Genetic variations of highly individual antioxidant enzymes significantly can either promote or hinder cancer cells ability to combat oxidative stress that influences lipid peroxidation [17, 259]
Hajihashemi, S., Noedoost, F., Geuns, J., Djalovic, I
Discontinuation rates were higher than in Phase 2 trials - 18.2% at the 12mg dose versus 4% with placebo
COACH'S TIPS No fat burner is a miracle product
The 2400mg dosage provides optimal therapeutic benefits